These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18199743)

  • 1. Peters Plus syndrome is a new congenital disorder of glycosylation and involves defective Omicron-glycosylation of thrombospondin type 1 repeats.
    Hess D; Keusch JJ; Oberstein SA; Hennekam RC; Hofsteenge J
    J Biol Chem; 2008 Mar; 283(12):7354-60. PubMed ID: 18199743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifies thrombospondin type 1 repeats.
    Heinonen TY; Maki M
    Ann Med; 2009; 41(1):2-10. PubMed ID: 18720094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peters plus syndrome mutations affect the function and stability of human β1,3-glucosyltransferase.
    Zhang A; Venkat A; Taujale R; Mull JL; Ito A; Kannan N; Haltiwanger RS
    J Biol Chem; 2021 Jul; 297(1):100843. PubMed ID: 34058199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of B3GALTL in Peters Plus syndrome.
    Reis LM; Tyler RC; Abdul-Rahman O; Trapane P; Wallerstein R; Broome D; Hoffman J; Khan A; Paradiso C; Ron N; Bergner A; Semina EV
    Am J Med Genet A; 2008 Oct; 146A(20):2603-10. PubMed ID: 18798333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase.
    Lesnik Oberstein SA; Kriek M; White SJ; Kalf ME; Szuhai K; den Dunnen JT; Breuning MH; Hennekam RC
    Am J Hum Genet; 2006 Sep; 79(3):562-6. PubMed ID: 16909395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First functional analysis of a novel splicing mutation in the B3GALTL gene by an ex vivo approach in Tunisian patients with typical Peters plus syndrome.
    Ben Mahmoud A; Siala O; Mansour RB; Driss F; Baklouti-Gargouri S; Mkaouar-Rebai E; Belguith N; Fakhfakh F
    Gene; 2013 Dec; 532(1):13-7. PubMed ID: 23954224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel nonsense B3GALTL mutation confirms Peters plus syndrome in a patient with multiple malformations and Peters anomaly.
    Aliferis K; Marsal C; Pelletier V; Doray B; Weiss MM; Tops CM; Speeg-Schatz C; Lesnik SA; Dollfus H
    Ophthalmic Genet; 2010 Dec; 31(4):205-8. PubMed ID: 21067481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Peters Plus syndrome-like phenotype with anterior eye staphyloma and hypoplastic left heart syndrome: proposal of a new syndrome.
    Shimizu R; Saito R; Hoshino K; Ogawa K; Negishi T; Nishimura J; Mitsui N; Osawa M; Ohashi H
    Congenit Anom (Kyoto); 2010 Sep; 50(3):197-9. PubMed ID: 20584037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Tunisian patients with Peters plus syndrome harbouring a novel splice site mutation in the B3GALTL gene that modulates the mRNA secondary structure.
    Siala O; Belguith N; Kammoun H; Kammoun B; Hmida N; Chabchoub I; Hchicha M; Fakhfakh F
    Gene; 2012 Oct; 507(1):68-73. PubMed ID: 22759511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peters plus syndrome.
    Kapoor S; Mukherjee SB; Arora R; Shroff D
    Indian J Pediatr; 2008 Jun; 75(6):635-7. PubMed ID: 18759095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism.
    Vasudevan D; Takeuchi H; Johar SS; Majerus E; Haltiwanger RS
    Curr Biol; 2015 Feb; 25(3):286-295. PubMed ID: 25544610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes.
    Weh E; Reis LM; Tyler RC; Bick D; Rhead WJ; Wallace S; McGregor TL; Dills SK; Chao MC; Murray JC; Semina EV
    Clin Genet; 2014 Aug; 86(2):142-8. PubMed ID: 23889335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing the Effects of O-Fucosylation on Secretion of ADAMTS Proteins Using Cell-Based Assays.
    Berardinelli SJ; Haltiwanger RS
    Methods Mol Biol; 2020; 2043():25-43. PubMed ID: 31463900
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhang A; Berardinelli SJ; Leonhard-Melief C; Vasudevan D; Liu TW; Taibi A; Giannone S; Apte SS; Holdener BC; Haltiwanger RS
    J Biol Chem; 2020 Nov; 295(46):15742-15753. PubMed ID: 32913123
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydrocephalus, agenesis of the corpus callosum, and cleft lip/palate represent frequent associations in fetuses with Peters' plus syndrome and B3GALTL mutations. Fetal PPS phenotypes, expanded by Dandy Walker cyst and encephalocele.
    Schoner K; Kohlhase J; Müller AM; Schramm T; Plassmann M; Schmitz R; Neesen J; Wieacker P; Rehder H
    Prenat Diagn; 2013 Jan; 33(1):75-80. PubMed ID: 23161355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Phenotype of Peters-Plus Syndrome.
    Shah PR; Chauhan B; Chu CT; Kofler J; Nischal KK
    Cornea; 2022 Feb; 41(2):219-223. PubMed ID: 34629439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertebral defects in patients with Peters plus syndrome and mutations in B3GALTL.
    Faletra F; Athanasakis E; Minen F; Fornasier F; Marchetti F; Gasparini P
    Ophthalmic Genet; 2011 Nov; 32(4):256-8. PubMed ID: 21671750
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency).
    Schollen E; Frank CG; Keldermans L; Reyntjens R; Grubenmann CE; Clayton PT; Winchester BG; Smeitink J; Wevers RA; Aebi M; Hennet T; Matthijs G
    J Med Genet; 2004 Jul; 41(7):550-6. PubMed ID: 15235028
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and characterization of abeta1,3-glucosyltransferase that synthesizes the Glc-beta1,3-Fuc disaccharide on thrombospondin type 1 repeats.
    Kozma K; Keusch JJ; Hegemann B; Luther KB; Klein D; Hess D; Haltiwanger RS; Hofsteenge J
    J Biol Chem; 2006 Dec; 281(48):36742-51. PubMed ID: 17032646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome.
    Dubail J; Vasudevan D; Wang LW; Earp SE; Jenkins MW; Haltiwanger RS; Apte SS
    Sci Rep; 2016 Sep; 6():33974. PubMed ID: 27687499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.